Showing results (1941-1950 of 2,029) with videos related to

Sort By:
Pageof 203
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
Sequence-Specific Pharmacokinetic and Pharmacodynamic Phase I/Ib Study of Olaparib Tablets and Carboplatin in Women's CancerJung-Min Lee, Cody J Peer, Minshu Yu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host diseaseTeresa Ramirez-Montagut, Andrew Chow, Adam A Kochman, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|November 26, 2009
Data File Standard for Flow Cytometry, version FCS 3.1Josef Spidlen, Wayne Moore, David Parks, et al.
BMC Genomics|July 20, 2013
Design and validation of a supragenome array for determination of the genomic content of Haemophilus influenzae isolatesRory A Eutsey, N Luisa Hiller, Joshua P Earl, et al.
Transfusion|June 24, 2022
Rate of D-alloimmunization in trauma does not depend on the number of RhD-positive units transfused: The BEST collaborative studyJansen N Seheult, Jeannie Callum, Meghan Delaney, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|April 12, 2019
Postnatal intervention for the treatment of FNAIT: a systematic reviewJillian M Baker, Nadine Shehata, James Bussel, et al.
Blood|July 23, 2005
CCR2 is required for CD8-induced graft-versus-host diseaseTheis H Terwey, Theo D Kim, Adam A Kochman, et al.
British Journal of Haematology|March 5, 2019
Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approachLani Lieberman, Andreas Greinacher, Michael F Murphy, et al.
Science (New York, N.Y.)|April 3, 2025
Integrating multiple evidence streams to understand insect biodiversity changeRob Cooke, Charlotte L Outhwaite, Andrew J Bladon, et al.
Gut|February 4, 2015
The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferonWesley A Grimm, Jeannette S Messer, Stephen F Murphy, et al.
Pageof 203